An Open Label, Multicenter, Single-arm Trial to Assess Safety and Efficacy of Alteplase (Rt-PA) in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
Phase of Trial: Phase III
Latest Information Update: 29 Dec 2017
At a glance
- Drugs Alteplase (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 20 Dec 2017 Status changed from active, no longer recruiting to completed.
- 20 Oct 2017 Planned End Date changed from 30 Nov 2017 to 11 Dec 2017.
- 20 Oct 2017 Planned primary completion date changed from 12 Oct 2017 to 11 Dec 2017.